OBIO
OBIO
NASDAQ · Health Care

Orchestra Biomed Holdings In

$3.98
+0.26 (+6.99%)
Financial Highlights (FY 2026)
Revenue
46.39M
Net Income
-73,025,784
Gross Margin
99.4%
Profit Margin
-157.4%
Rev Growth
+111.7%
D/E Ratio
0.23
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.4% 52.2% 52.2% 52.2%
Operating Margin -154.7% 14.5% 14.7% 14.2%
Profit Margin -157.4% 15.4% 15.8% 15.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 46.39M 68.62M 71.19M 67.09M
Gross Profit 46.13M 35.85M 37.19M 35.05M
Operating Income -71,779,804 9.92M 10.44M 9.52M
Net Income -73,025,784 10.58M 11.27M 10.19M
Gross Margin 99.4% 52.2% 52.2% 52.2%
Operating Margin -154.7% 14.5% 14.7% 14.2%
Profit Margin -157.4% 15.4% 15.8% 15.2%
Rev Growth +111.7% -5.8% -4.6% -3.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 22.61M 31.41M 32.93M 31.53M
Total Equity 100.44M 72.86M 78.63M 70.41M
D/E Ratio 0.23 0.43 0.42 0.45
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -71,332,126 14.36M 13.60M 15.28M
Free Cash Flow 6.20M 6.53M 6.19M